Grant

A Phase Ib Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer

Sponsored by Hoffman-La Roche Incorporated

Active

$548.3K Funding

1 People

External

Related Topics

ovarian cancer, combination therapy, precision medicine, immunotherapy, platinum-sensitive

People

Setsuko Chambers
Principal Investigator (PI)
Obstetrics and Gynecology﹒Professor